ROIV
NASDAQ · Biotechnology
Roivant Sciences Ltd
$36.34
+1.22 (+3.47%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+121.3% upside
Low Target
$62.72
Average Target
$80.43
High Target
$106.86
Current Price
$36.34
Current
$36.34
$36.34
Target
$80.43
$80.43
$62.72
$80.43 avg
$106.86
Scenario Analysis
Bear Case
$62.72
72.6%
Low target
Base Case
$80.43
+121.3%
Avg target
Bull Case
$106.86
+194.1%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$37.00
-1.8% from high
52-Week Low
$10.90
+233.4% from low
50-Day SMA
$23.00
+58.0% vs SMA
200-Day SMA
$16.34
+122.4% vs SMA
RSI (14)
76.4
Overbought
Target vs 52W High
$80.43
+117.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |